Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 5/20 | 0.36 |
| ▸ | TET3 | O43151 | 1/20 | 0.36 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.34 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.34 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.32 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7758820 | 0.92 | TET2 (0.40) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL16661 | 0.92 | — | — | |
| SCHEMBL30849720 | 0.89 | — | — | |
| SCHEMBL4532573 | 0.89 | TET2 (0.39) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL29150247 | 0.89 | — | — | |
| Ethylene SCHEMBL7184477 | 0.89 | TET2 (0.39) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL5698428 | 0.86 | GRIK1 (0.41) | TET2TET3TET1GRIK1GRIK2 | |
| Tetrahydrofuran SCHEMBL28177749 | 0.86 | ALDH1A1 (0.35) | TET2TET3TET1GRIK1GRIK2 | |
| Urea SCHEMBL29140399 | 0.84 | GRIK1 (0.39) | TET2TET3TET1GRIK1GRIK2 | |
| SCHEMBL9340610 | 0.84 | TET2 (0.36) | TET2TET3TET1GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220145105-A1 | ELECTRON BEAM-CURABLE PRINTING INK COMPOSITION AND ELECTRON BEAM-CURABLE OVERPRINT VARNISH COMPOSITION | SAKATA INX CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20220056286-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION | SAKATA INX CORPORATION (JP) | 2022-02-24 | — | — | US | disclosed |
| US-20220056287-A1 | ACTIVE ENERGY RAY-CURABLE FLEXOGRAPHIC PRINTING INK COMPOSITION | SAKATA INX CORPORATION (JP) | 2022-02-24 | — | — | US | disclosed |
| EP-3940033-A1 | ELECTRON BEAM CURABLE PRINTING INK COMPOSITION AND ELECTRON BEAM CURABLE OVERPRINT VARNISH COMPOSITION | Sakata INX Corporation (JP) | 2022-01-19 | — | — | EP | disclosed |
| EP-3904395-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION | Sakata INX Corporation (JP) | 2021-11-03 | — | — | EP | disclosed |
| EP-3901225-A1 | ACTIVE ENERGY RAY-CURABLE FLEXOGRAPHIC PRINTING INK COMPOSITION | Sakata INX Corporation (JP) | 2021-10-27 | — | — | EP | disclosed |
| US-10619058-B2 | Curable composition | TOAGOSEI CO., LTD. (JP) | 2020-04-14 | — | — | US | disclosed |
| US-10611856-B2 | Curable composition | TOAGOSEI CO., LTD. (JP) | 2020-04-07 | — | — | US | disclosed |
| EP-3569664-A1 | ACTIVE ENERGY RAY-CURABLE INK COMPOSITION FOR OFFSET PRINTING AND METHOD FOR PRODUCING PRINTED MATERIAL USING SAME | Sakata INX Corporation (JP) | 2019-11-20 | — | — | EP | disclosed |
| US-20180237629-A1 | CURABLE COMPOSITION | TOAGOSEI CO., LTD. (JP) | 2018-08-23 | — | — | US | disclosed |
| US-20130065982-A1 | CURING-TYPE COATING-AGENT COMPOSITION | TOAGOSEI CO., LTD. (JP) | 2013-03-14 | — | — | US | disclosed |
| US-20130065062-A1 | MEMBER FOR VEHICLE AND MANUFACTURING PROCESS FOR THE SAME | KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) | 2013-03-14 | — | — | US | disclosed |
| US-8362100-B2 | Ink curable with actinic energy ray and printed matter | TOKYO INK MFG. CO., LTD. (JP) | 2013-01-29 | — | — | US | disclosed |
| US-20120244361-A1 | VEHICLE MEMBER AND PROCESS FOR PRODUCING THE SAME | KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) | 2012-09-27 | — | — | US | disclosed |
| US-20110319582-A1 | CURABLE COMPOSITION COMPRISING INORGANIC OXIDE MICROPARTICLES THAT ARE SURFACE-MODIFIED WITH MALEIMIDE GROUPS | TOAGOSEI CO., LTD. (JP) | 2011-12-29 | — | — | US | disclosed |
| US-7928322-B2 | Conductive ink, conductive circuit and non-contact media | TOYO INK MFG. CO., LTD. (JP) | 2011-04-19 | — | — | US | disclosed |
| US-20100304098-A1 | INK CURABLE WITH ACTINIC ENERGY RAY AND PRINTED MATTER | TOYO INK MFG. CO., LTD. (JP) | 2010-12-02 | — | — | US | disclosed |
| EP-2177577-A1 | INK CURABLE WITH ACTINIC ENERGY RAY AND PRINTED MATTER | Toyo Ink Manufacturing CO., LTD. (JP) | 2010-04-21 | — | — | EP | disclosed |
| US-20100051333-A1 | CONDUCTIVE INK, CONDUCTIVE CIRCUIT AND NON-CONTACT MEDIA | TOYO INK MFG. CO., LTD. (JP) | 2010-03-04 | — | — | US | disclosed |
| EP-2078738-A1 | CONDUCTIVE INK, CONDUCTIVE CIRCUIT AND NON-CONTACT MEDIA | Toyo Ink Manufacturing CO., LTD. (JP) | 2009-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10611856-B2 | Curable composition | ACR, KAT2B, KAT5 | TET2 122/4885TET3 144/4885TET1 124/4885 |
| US-20110319582-A1 | CURABLE COMPOSITION COMPRISING INORGANIC OXIDE MICROPARTICLES THAT ARE SURFACE-MODIFIED WITH MALEIMIDE GROUPS | WDR1, SKP1, CCNT1 | TET2 1680/4885TET3 1375/4885TET1 606/4885 |
| US-10619058-B2 | Curable composition | ZMYND8, AZI2, KAT2A | TET2 41/4885TET3 42/4885TET1 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.